Assignee
PHARMACYCLICS LLC
US·65 granted patents·102 pending applications·749 citations·filing 2012–2025
Top patents by PatentIndex Score
167 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0399US9409911B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2013·Granted Aug 9, 2016·42 cites·18 claims
- 0499US9266893B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Feb 23, 2016·40 cites·7 claims
- 0598US10751342B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·5 cites·13 claims
- 0698US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0798US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0898US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0997US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 1097US10653696B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2019·Granted May 19, 2020·5 cites·9 claims
- 1197US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 1297US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 1397US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1496US10478439B2Use of inhibitors of bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2018·Granted Nov 19, 2019·8 cites·17 claims
- 1596US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 1696US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 1796US10016435B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jul 10, 2018·12 cites·8 claims
- 1896US10004746B2Use of inhibitors of Bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2017·Granted Jun 26, 2018·9 cites·30 claims
- 1996US9814721B2Use of inhibitors of bruton'S tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2016·Granted Nov 14, 2017·14 cites·11 claims
- 2096US9801883B2Use of inhibitors of bruton's tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Oct 31, 2017·11 cites·31 claims
- 2195US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 2295US10010507B1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Jul 3, 2018·23 cites·28 claims
- 2395US9801881B2Use of inhibitors of bruton's tyrosine kinase (BTK)PHARMACYCLICS LLC·Filed 2013·Granted Oct 31, 2017·13 cites·18 claims
- 2495US9655857B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted May 23, 2017·32 cites·37 claims
- 2595US9556182B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 31, 2017·11 cites·22 claims
- 2694US11672803B2Use of inhibitors of Brutons tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2020·Granted Jun 13, 2023·2 cites·24 claims
- 2794US10828259B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Nov 10, 2020·5 cites·25 claims
- 2894US10695350B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2019·Granted Jun 30, 2020·6 cites·8 claims
- 2994US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 3094US10213386B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Feb 26, 2019·18 cites·23 claims
- 3194US10004745B2Use of inhibitors of Bruton'S tyrosine kinase (Btk)PHARMACYCLICS LLC·Filed 2016·Granted Jun 26, 2018·7 cites·7 claims
- 3294US9540385B2Pyrrolopyrimidine compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2015·Granted Jan 10, 2017·18 cites·26 claims
- 3394US9415050B2Methods for the treatment of HER2 amplified cancerPHARMACYCLICS LLC·Filed 2014·Granted Aug 16, 2016·17 cites·21 claims
- 3493US9795604B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2014·Granted Oct 24, 2017·19 cites·55 claims
- 3593US2024358707A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 3692US9545407B2Formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2015·Granted Jan 17, 2017·51 cites·6 claims
- 3791US10463668B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Granted Nov 5, 2019·8 cites·4 claims
- 3891US9795605B2Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumorsPHARMACYCLICS LLC·Filed 2015·Granted Oct 24, 2017·6 cites·22 claims
- 3991US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 4091US9421208B2Methods for the treatment of solid tumorsPHARMACYCLICS LLC·Filed 2014·Granted Aug 23, 2016·7 cites·15 claims
- 4190US9730938B2Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2015·Granted Aug 15, 2017·16 cites·23 claims
- 4289US10105552B2Formulations of histone deacetylase inhibitor and uses thereofPHARMACYCLICS LLC·Filed 2016·Granted Oct 23, 2018·2 cites·15 claims
- 4389US9533991B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 4489US2023293532A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 4589US2023248730A1Use of inhibitors of brutons tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 4688US9403032B2Formulations of histone deacetylase inhibitor and uses therofPHARMACYCLICS LLC·Filed 2013·Granted Aug 2, 2016·3 cites·17 claims
- 4788US2025197404A1Synthesis of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 4888US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 4988US2025345335A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 5087US2025127781A1Use of inhibitors of bruton's tyrosine kinase (btk)PHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
Showing the top 50 of 167 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →